deadline.com
93%
566
FDA And CDC Recommend Pausing Johnson & Johnson Covid Vaccine During Investigation Of Reports Of “Extremely Rare” Blood Clots
The Food and Drug Administration and the Centers for Disease Control are recommending a pause on the Johnson & Johnson Covid vaccine after reports of what the agencies characterize as an “extremely rare” blood clot.